Recombinant Human NOV

Home/Recombinant Proteins/Recombinant Human NOV

Pricing & Details

Product. No.N141
Alternate Names
CCN3, IGFBP9, NovH
Expression Host
E. coli
Species
Human
Prod No.
Size
Price
Avail.
Qty
Add to cart
N141-5 µg
5 µg
$221.00
In stock
Max:
Min: 1
Step: 1
N141-20 µg
20 µg
$347.00
In stock
Max:
Min: 1
Step: 1

Background

Nephroblastoma overexpressed gene, also known as NOV is a member of the CCN (connective tissue growth factor [CTGF]) family of proteins. These proteins are cysteine-rich and are noted for having growth-regulatory functions.1 NOV is highly expressed in the nervous system.2 NOV is a specific cell fate regulator in the myogenic lineage, acting negatively on key myogenic genes thus controlling the transition from progenitor cells to myoblasts.3 NOV also supports endothelial cell adhesion and angiogenesis through interactions with integrins.4

Protein Details

Purity
>95% by SDS Page and HPLC
Endotoxin Level
<0.1 EU/µg as determined by the LAL method
Expression Host
E. coli
State of Matter
Lyophilized
Predicted Molecular Mass
The predicted molecular weight of Recombinant Human NOV is Mr 37.1 kDa. However, the actual molecular weight as observed by migration on SDS Page is Mr 55 kDa.
Storage and Stability
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Country of Origin
USA
Shipping
Next Day Ambient
NCBI Gene Bank

References & Citations

1. Maki RA. et al. (1999) Gene 238: 471 2. Kleinman HK. et al. (2003) FASEB J. 17: 1919 3. Dubois C. et al. (2006) Exp Cell Resp. 312: 1876 4. Martinerie C. et al. (2005) Cell Commun Adhes. 12: 41
IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok